PlumX Metrics
Embed PlumX Metrics

Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study

Open Forum Infectious Diseases, ISSN: 2328-8957, Vol: 11, Issue: 1, Page: ofad626
2024
  • 2
    Citations
  • 0
    Usage
  • 7
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    2
  • Captures
    7
  • Mentions
    2
    • News Mentions
      2
      • News
        2

Most Recent News

Data from ViiV Healthcare Provide New Insights into Biomarkers (Very-low-level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-year Results of the Randomized Tango Study)

2024 FEB 09 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Daily -- Current study results on Diagnostics and Screening - Biomarkers

Article Description

Background. We compared proportions of participants with target detected, target not detected (TND), and elevated viral load (VL) and assessed baseline variables associated with week 144 inflammatory biomarker levels between dolutegravir-lamivudine (DTG/3TC) and tenofovir alafenamide–based regimens (TBRs) in the TANGO study (post hoc). Methods. TANGO is an open-label, multicenter, phase 3 study that randomized adults with VL <50 copies/mL to switch to once-daily fixed-dose DTG/3TC or continue TBR. At baseline and each study visit, the VL was measured. Elevated VL event frequencies were assessed, including “blips.” Interleukin 6, D-dimer, high-sensitivity C-reactive protein, soluble CD14, and soluble CD163 were measured at baseline and at week 144. Log-transformed week 144 biomarker levels were compared between treatment groups using an analysis of covariance model adjusting for baseline variables. Results. High, comparable proportions of participants had VL <40 copies/mL and TND at week 144 (DTG/3TC, 279 of 369 [76%]; TBR, 267 of 372 [72%], intention-to-treat exposed Snapshot analysis; adjusted difference, 3.9% [95% confidence interval, −2.5% to 10.2%]), with similar TND proportions at all postbaseline visits (123 of 369 [33%] vs 101 of 372 [27%], respectively). Similar proportions of DTG/3TC participants had ≥1 postbaseline VL ≥50 copies/mL (28 of 369 [8%] vs 42 of 372 [11%] for TBR), primarily blips (18 of 369 [5%] and 26 of 372 [7%], respectively). Week 144 inflammatory biomarker levels were low and comparable between groups and associated with multiple demographic and baseline characteristics, including baseline biomarker levels, indicating a multifactorial inflammatory response. Conclusions. Week 144 biomarker levels were low and generally comparable between treatment groups, reflecting similar, robust, and durable viral suppression observed using the stringent TND end point.

Bibliographic Details

Wang, Ruolan; Underwood, Mark; Llibre, Josep M; Bernal Morell, Enrique; Brinson, Cynthia; Sanz Moreno, José; Scholten, Stefan; Moore, Richard; Saggu, Parminder; Oyee, James; Moodley, Riya; Wynne, Brian; Kisare, Michelle; Jones, Bryn; Ait-Khaled, Mounir

Oxford University Press (OUP)

Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know